A clinical trial to study the effect of Agnidamani in comparison to Kantakari in the patients having cough

Evaluation of Kasaharakarma of Agnidamani (Solanum trilobatum Linn) as an alternative to Kantakari (Solanum xanthocarpum Schard and H Wendl) therapeutically - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081964

Enrollment

Registered

2025-03-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R05- Cough

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having classical signs and symptoms of Kasa and minimum 2 associated symptoms of Doshaja Kasa based on Ayurvedic classical texts. 2.Uncomplicated cases of Kasa. 3.Age group 18 to 60 years. 4.Chronicity less than 1 month. 5.Newly diagnosed cases of Kasa.

Exclusion criteria

Exclusion criteria: 1.Patients suffering from any systemic disorder (like Tuberculosis, Asthma, and Diabetes Mellitus and others) and Kasa as a complication of any disease will be excluded from the study. 2.Asadhya or Yapya Kasa like Kshayaja and Kshataja. 3.Other complicated respiratory diseases having any organic lesion such as tumor or any anatomical defect in airway. 4.Uncontrolled systemic disorders like Hypertension (more than 160/100 mmHg), Diabetes Mellitus (RBS more than 180 mg/dl). 5.Pregnant women and lactating mothers.

Design outcomes

Primary

Measure	Time frame
Improvement in signs and symptoms will be assessed on the basis of changes in scoring patterns developed for grading of the clinical factors on 0th,7th day.Timepoint: 7th day	—

Secondary

Measure	Time frame
Not ApplicableTimepoint: Nil	—

Countries

India

Contacts

Public ContactKrishna Vipulbhai Soni

Institute of Teaching and Research in Ayurveda

brpayu@itra.edu.in7487876343

Outcome results